Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Drug sellers ‘take vacations’ amid China anti-graft campaign

Pharmas have told their sales teams to halt all activity in China to avoid being caught in the nationwide “enforcement storm,” according to the Guangdong-based Yangcheng Evening News.

“It is rumored that police in plain clothes are patrolling in hospitals; drug sales representatives will be fined 500 yuan ($81) and regional sales managers 1000 yuan ($162) once being caught in hospitals,” an unidentified sales representative told the paper.Continue Reading

Pharma jobs for compliance pros

Among the many hundreds of listings in all industries, here are some compliance positions for pharmas currently displayed on FCPA Jobs:

Chief Compliance Officer
Wegman Partners – Research Triangle Park, North Carolina
Wegman Partners has been engaged to seek a Chief Compliance Officer to report to the CEO of a specialty pharmaceutical company.

Continue Reading

Docs collect billions for drug promos

ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.

A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading

After SEC settlement, Lilly waits for DOJ decision

Indiana-based pharma Eli Lilly said Thursday that although it paid $29.4 million to settle FCPA offenses with the SEC, it believes the DOJ’s longstanding investigation is still open.

The SEC charged Lilly in December last year with bribing government officials in Russia, Brazil, China, and Poland.… Continue Reading

Eli Lilly pays $29 million in SEC settlement

Eli Lilly and Company resolved FCPA civil charges brought by the Securities and Exchange Commission based on bribes to government officials in Russia, Brazil, China, and Poland.

Lilly agreed Thursday to pay $29.4 million to the SEC.… Continue Reading